MYB and breast carcinoma: For example, Mapper was recently used to extract information from high-throughput microarray data and define a new subtype of breast cancer, c-MYB+, characterized by high c-MYB expression and low levels of innate inflammatory genes, with corresponding patients exhibiting 100% survival and no metastasis (Nicolau et al., 2007).